908 Devices (MASS) Income from Discontinued Operations (2024 - 2025)
908 Devices (MASS) posted quarterly Income from Discontinued Operations of 204000.0 for Q4 2025, up 387.32% year-over-year from 41861.27 in Q4 2024, and up 1375.0% quarter-over-quarter from 16000.0 in Q1 2025.
908 Devices (MASS) Income from Discontinued Operations (2024 - 2025) Analysis & Trends
908 Devices (MASS) has reported Income from Discontinued Operations for 2 consecutive years, with 204000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Income from Discontinued Operations rose 387.32% year-over-year to 204000.0; the TTM figure through Dec 2025 stood at 188000.0 (up 166.67% YoY), while the FY2025 annual figure was 188000.0, up 166.67% from the prior year.
- Income from Discontinued Operations advanced to 204000.0 in Q4 2025 per MASS's latest filing, from 16000.0 in the prior quarter.
- Across five years, Income from Discontinued Operations topped out at 204000.0 in Q4 2025 and bottomed at 72000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | 908 Devices | 382.56 Mn | 281.03 Mn | 8.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 204,000.00 |
| Mar 31, 2025 | -16,000.00 |
| Dec 31, 2024 | -71,000.00 |
| Sep 30, 2024 | -72,000.00 |
| Jun 30, 2024 | -69,000.00 |
| Mar 31, 2024 | -70,000.00 |